Hexcel Corporation and Subsidiaries Condensed Consolidated Balance Sheets (Unaudited) June 30, December 31, (In millions) 2026 2025 Assets Current assets: Cash and cash equivalents $ 62.2 $ 71.0 Accounts receivable, net 299.2 249.3 Inventories, net 345.2 328.8 Contract assets 41.6 35.9 Prepaid expenses and other current assets 44.0 45.7 Total current assets 792.2 730.7 Property, plant and equipment 3,324.2 3,322.4 Less accumulated depreciation (1,743.1 ) (1,710.9 ) Net property, plant and equipment 1,581.1 1,611.5 Goodwill and other intangible assets, net 235.6 239.8 Investments in affiliated companies 5.0 5.0 Other assets 116.7 117.0 Total assets $ 2,730.6 $ 2,704.0 Liabilities and Stockholders' Equity Current liabilities: Accounts payable $ 144.6 $ 146.6 Accrued compensation and benefits 73.3 79.0 Financial instruments 4.5 3.8 Accrued liabilities 104.0 93.3 Total current liabilities 326.4 322.7 Long-term debt 959.4 993.0 Retirement obligations 28.8 28.4 Deferred income taxes 88.7 86.7 Other non-current liabilities 29.1 22.5 Total liabilities 1,432.4 1,453.3 Stockholders' equity: Common stock, $0.01 par value, 200.0 shares authorized, 112.7 shares and 112.1 shares issued at June 30, 2026 and December 31, 2025, respectively 1.1 1.1 Additional paid-in capital 1,002.3 994.9 Retained earnings 2,366.2 2,307.0 Accumulated other comprehensive loss (43.8 ) (12.9 ) 3,325.8 3,290.1 Less – Treasury stock, at cost, 37.2 shares at June 30, 2026 and 36.4 shares at December 31, 2025 (2,027.6 ) (2,039.4 ) Total stockholders' equity 1,298.2 1,250.7 Total liabilities and stockholders' equity $ 2,730.6 $ 2,704.0 The accompanying notes are an integral part of these condensed consolidated financial statements. 3 Hexcel Corporation and Subsidiaries Condensed Consolidated Statements of Operations (Unaudited) (Unaudited) Quarters Ended June 30, Six Months Ended June 30, (In millions, except per share data) 2026 2025 2026 2025 Net sales $ 529.3 $ 489.9 $ 1,030.8 $ 946.4 Cost of sales 391.2 378.4 758.0 732.5 Gross margin 138.1 111.5 272.8 213.9 Selling, general and administrative expenses 47.2 43.0 96.6 86.3 Research and development expenses 17.3 14.3 35.1 28.1 Other operating expense 1.0 24.2 10.9 25.3 Operating income 72.6 30.0 130.2 74.2 Interest expense, net 12.0 9.1 23.8 16.9 Other (income) expense (0.1 ) (0.9 ) 0.2 (0.5 ) Income before income taxes 60.7 21.8 106.2 57.8 Income tax expense 11.4 8.3 19.7 15.4 Net income $ 49.3 $ 13.5 $ 86.5 $ 42.4 Basic net income per common share $ 0.65 $ 0.17 $ 1.14 $ 0.53 Diluted net income per common share $ 0.64 $ 0.17 $ 1.13 $ 0.52 Weighted-average common shares: Basic 75.7 80.2 75.8 80.7 Diluted 76.5 80.6 76.6 81.1 Hexcel Corporation and Subsidiaries Condensed Consolidated Statements of Comprehensive Income (Unaudited) (Unaudited) Quarters Ended June 30, Six Months Ended June 30, (In millions) 2026 2025 2026 2025 Net income $49.3 $13.5 $86.5 $42.4 Currency translation adjustments (6.4) 51.1 (20.0) 75.4 Net unrealized pension and other benefit actuarial losses and prior service credits (net of tax) — (0.8) (0.2) (0.8) Net unrealized (losses) gains on financial instruments (net of tax) (6.9) 17.4 (10.7) 26.8 Total other comprehensive income (loss) (13.3) 67.7 (30.9) 101.4 Comprehensive income $36.0 $81.2 $55.6 $143.8 The accompanying notes are an integral part of these condensed consolidated financial statements. 4 Hexcel Corporation and Subsidiaries Condensed Consolidated Statements of Cash Flows (Unaudited) Six Months Ended June 30, (In millions) 2026 2025 Cash flows from operating activities Net income $ 86.5 $ 42.4 Reconciliation to net cash provided by (used for) operating activities: Depreciation and amortization 60.5 60.6 Amortization related to financing 0.8 0.1 Deferred income taxes 8.0 (2.7 ) Stock-based compensation 14.5 12.4 Restructuring expenses, net of payments 2.1 23.1 Debt extinguishment costs 0.7 0.4 Loss on divestiture of assets — 1.1 Changes in assets and liabilities: Increase in accounts receivable (52.0 ) (44.2 ) (Increase) decrease in inventories (22.0 ) 7.2 Increase in prepaid expenses and other current assets (9.3 ) (19.5 ) Increase (decrease) in accounts payable/accrued liabilities 11.1 (68.0 ) Other – net (4.2 ) (18.1 ) Net cash provided by (used for) operating activities 96.7 (5.2 ) Cash flows from investing activities Capital expenditures (44.9 ) (41.4 ) Payments on divestiture of assets — (1.1 ) Net cash used for investing activities (44.9 ) (42.5 ) Cash flows from financing activities Borrowing from senior unsecured credit facility - 2028 15.0 160.0 Repayment of senior unsecured credit facility - 2028 (310.0 ) (30.0 ) Borrowing from senior unsecured credit facility - 2031 580.0 — Repayment of senior unsecured credit facility - 2031 (315.0 ) — Redemption of 4.7% senior notes due 2025 — (300.0 ) Proceeds from issuance of 5.875% senior notes due 2035 — 300.0 Redemption of 3.95% senior notes due 2027 (400.0 ) — Proceeds from issuance of 4.9% senior notes due 2031 400.0 — Repurchases of common stock — (100.9 ) Issuance costs related to senior unsecured credit facilities (2.3 ) — Issuance costs related to senior notes (4.6 ) (4.1 ) Repayment of finance lease obligation and other debt, net (0.2 ) 0.2 Dividends paid (27.3 ) (27.5 ) Activity under stock plans 4.7 (1.8 ) Net cash used for financing activities (59.7 ) (4.1 ) Effect of exchange rate changes on cash and cash equivalents (0.9 ) 3.6 Net decrease in cash and cash equivalents (8.8 ) (48.2 ) Cash and cash equivalents at beginning of period 71.0 125.4 Cash and cash equivalents at end of period $ 62.2 $ 77.2 Supplemental data: Accrual basis additions to plant, property and equipment $ 37.2 $ 31.8 The accompanying notes are an integral part of these condensed consolidated financial statements. 5 Hexcel Corporation and Subsidiaries Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) For the Quarters and Six Months ended June 30, 2026, and June 30, 2025 Accumulated Additional Other Total Paid-In Retained Comprehensive Treasury Stockholders’ (In millions) Par Capital Earnings Loss Stock Equity Balance, December 31, 2024 $ 1.1 $ 970.0 $ 2,251.5 $ (115.0 ) $ (1,579.7 ) $ 1,527.9 Net income — — 28.9 — — 28.9 Dividends on common stock ($0.17 per share) — — (13.8 ) — — (13.8 ) Repurchases of common stock — — — — (50.4 ) (50.4 ) Change in other comprehensive loss– net of tax — — — 33.7 — 33.7 Stock-based activity — 11.0 — — (4.7 ) 6.3 Balance, March 31, 2025 $ 1.1 $ 981.0 $ 2,266.6 $ (81.3 ) $ (1,634.8 ) $ 1,532.6 Net income — — 13.5 — — 13.5 Dividends on common stock ($0.17 per share) — — (13.7 ) — — (13.7 ) Repurchases of common stock — — — — (50.5 ) (50.5 ) Change in other comprehensive loss– net of tax — — — 67.7 — 67.7 Stock-based activity — 4.4 — — (0.1 ) 4.3 Balance, June 30, 2025 $ 1.1 $ 985.4 $ 2,266.4 $ (13.6 ) $ (1,685.4 ) $ 1,553.9 Accumulated Additional Other Total Paid-In Retained Comprehensive Treasury Stockholders’ (In millions) Par Capital Earnings Loss Stock Equity Balance, December 31, 2025 $ 1.1 $ 994.9 $ 2,307.0 $ (12.9 ) $ (2,039.4 ) $ 1,250.7 Net income — — 37.2 — — 37.2 Dividends on common stock ($0.18 per share) — — (13.7 ) — — (13.7 ) Repurchases of common stock — (16.4 ) — — 16.4 - Change in other comprehensive (loss) income– net of tax — — — (17.6 ) — (17.6 ) Stock-based activity — 14.0 — — (4.4 ) 9.6 Balance, March 31, 2026 $ 1.1 $ 992.5 $ 2,330.5 $ (30.5 ) $ (2,027.4 ) $ 1,266.2 Net income — — 49.3 — — 49.3 Dividends on common stock ($0.18 per share) — — (13.6 ) — — (13.6 ) Change in other comprehensive loss– net of tax — — — (13.3 ) — (13.3 ) Stock-based activity — 9.8 — — (0.2 ) 9.6 Balance, June 30, 2026 $ 1.1 $ 1,002.3 $ 2,366.2 $ (43.8 ) $ (2,027.6 ) $ 1,298.2 The accompanying notes are an integral part of these condensed consolidated financial statements. 6 HEXCEL CORPORATION AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) Note 1 — Significant Accounting Policies In these notes, the terms “Hexcel,” “the Company,” “we,” “us,” or “our” mean Hexcel Corporation and subsidiary companies. The accompanying condensed consolidated financial statements are those of Hexcel Corporation. Refer to Note 1 to the consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2025 for a discussion of our significant accounting policies. Basis of Presentation The accompanying condensed consolidated financial statements have been prepared from the unaudited accounting records of Hexcel pursuant to rules and regulations of the Securities and Exchange Commission (“SEC”) and in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information. Certain information and footnote disclosures normally included in financial statements have been omitted pursuant to rules and regulations of the SEC. In the opinion of management, the condensed consolidated financial statements include all normal recurring adjustments as well as any non-recurring adjustments necessary to present fairly the statement of financial position, results of operations, cash flows and statement of stockholders’ equity for the interim periods presented. The Condensed Consolidated Balance Sheet as of December 31, 2025 was derived from the audited 2025 consolidated balance sheet. Interim results are not necessarily indicative of results expected for any other interim period or for the full year. These consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our 2025 Annual Report on Form 10-K. Commencing with the first quarter of 2026, we have renamed our Research and Technology ("R&T") function to Research and Development ("R&D"). Note 2 — Net Income Per Common Share Quarters Ended June 30, Six Months Ended June 30, (In millions, except per share data) 2026 2025 2026 2025 Basic net income per common share: Net income $ 49.3 $ 13.5 $ 86.5 $ 42.4 Weighted average common shares outstanding 75.7 80.2 75.8 80.7 Basic net income per common share $ 0.65 $ 0.17 $ 1.14 $ 0.53 Diluted net income per common share: Net income $ 49.3 $ 13.5 86.5 42.4 Weighted average common shares outstanding — Basic 75.7 80.2 75.8 80.7 Plus incremental shares from assumed conversions: Restricted stock units 0.4 0.3 0.4 0.3 Stock options 0.4 0.1 0.4 0.2 Weighted average common shares outstanding — Dilutive 76.5 80.6 76.6 81.1 Diluted net income per common share $ 0.64 $ 0.17 $ 1.13 $ 0.52 Total common stock equivalents of 0.1 million and 1.2 million were excluded from the computation of diluted net income per share for the quarters ended June 30, 2026 and 2025, respectively, because to include would have been anti-dilutive. Total common stock equivalents of 0.1 million and 1.1 million were excluded from the computation of diluted net income per share for the six months ended June 30, 2026 and 2025, respectively, because to include would have been anti-dilutive. 7 Note 3 — Inventories (In millions) June 30, 2026 December 31, 2025 Raw materials $ 182.5 $ 150.7 Work in progress 45.6 42.3 Finished goods 117.1 135.8 Total Inventory $ 345.2 $ 328.8 Note 4 — Retirement and Other Postretirement Benefit Plans We maintain qualified defined benefit retirement plans covering certain current and former European employees, as well as nonqualified defined benefit retirement plans, and retirement savings plans covering certain eligible U.S. and European employees and participate in a union sponsored multi-employer pension plan covering certain U.S. employees with union affiliations. In addition, we provide certain postretirement health care and life insurance benefits to eligible U.S. retirees. Defined Benefit Retirement Plans We have nonqualified defined benefit retirement plans covering certain current and former employees that are funded as benefits are incurred. Expense related to the defined benefit retirement plans for the quarters ended June 30, 2026 and 2025 was $0.3 million and $0.5 million, respectively. Expense related to the defined benefit retirement plans for the six months ended June 30, 2026 and 2025 was $0.7 million and $1.0 million, respectively. Postretirement Health Care and Life Insurance Benefit Plans We provide certain postretirement health care and life insurance benefits to eligible retirees. Depending upon the plan, benefits are available to eligible employees who retire after meeting certain age and service requirements and were employed by Hexcel as of February 1996. Our funding policy for the postretirement health care and life insurance benefit plans is generally to pay covered expenses as they are incurred. Net periodic benefit costs of our postretirement health care and life insurance benefit plans for the quarters and six months ended June 30, 2026 and 2025 were not material. Note 5 –– Debt (In millions) June 30, 2026 December 31, 2025 Senior unsecured credit facility $ 265.0 $ 295.0 3.95% senior notes --- due 2027 - 400.0 5.875% senior notes --- due 2035 300.0 300.0 4.9% senior notes --- due 2031 400.0 - Senior notes --- original issue discount (0.4 ) (0.2 ) Senior notes --- deferred financing costs (7.1 ) (3.9 ) Non-current portion of finance lease and other debt 1.9 2.1 Long-term debt 959.4 993.0 Total debt $ 959.4 $ 993.0 On March 31, 2026, the Company entered into a new credit agreement (the “Credit Agreement”) to refinance its senior unsecured credit facility (the “Facility”). Under the terms of the Credit Agreement the borrowing capacity remained at $750 million. The Facility matures on March 31, 2031. In connection with the refinancing, the Company incurred approximately $1.9 million in financing costs which were deferred and will be amortized over the term of the Facility. In addition, the Company recorded a charge of approximately $0.3 million in Other expense on the Condensed Consolidated Statements of Operations for closing costs related to the refinancing. Borrowings under the Facility bear interest, at Hexcel’s option, for SOFR rate borrowings at (i) an Adjusted Term SOFR rate (subject to a 0.00% floor), where such “Adjusted Term SOFR” rate is equal to the Term SOFR rate for the applicable interest period, plus the Applicable Margin or (ii) for base rate borrowings, the greatest of (a) the prime rate, (b) the federal funds rate plus 0.50% and (c) the Adjusted Term SOFR rate (subject to a 0.00% floor) for a one-month interest period plus 1.00%, in each case plus the 8 Applicable Margin. The “Applicable Margin” initially was 1.125% for SOFR rate borrowings and 0.125% for base rate borrowings, and after the date on which the Agent received a compliance certificate for the fiscal quarter ended March 31, 2026, can fluctuate, determined by reference to the more favorable to Hexcel of its (x) public debt rating and (y) consolidated leverage ratio, as specified in the Credit Agreement. Up to $50 million of the Facility may be used for letters of credit. The Credit Agreement enables Hexcel, from time to time, to add term loans or to increase the revolving credit commitment in an aggregate amount not to exceed $500 million. As of June 30, 2026, total borrowings under the Facility were $265.0 million which approximated fair value. Outstanding letters of credit reduce the amount available for borrowing under the Facility. As of June 30, 2026, there were no issued letters of credit under the Facility, resulting in undrawn availability under the Facility of $485.0 million. The weighted average interest rate for the Facility was 4.77% for the three months ended June 30, 2026. The Company was in compliance with all debt covenants as of June 30, 2026. During the second quarter of 2026, the Company issued $400 million in aggregate principal amount of 4.9% Senior Unsecured Notes due in 2031. The interest rate on these senior notes may be increased by 0.25% each time a credit rating applicable to the notes is downgraded. The maximum rate is 6.9%. Interest on the notes will be payable semiannually in arrears on May 15 and November 15 of each year, beginning on November 15, 2026. The effective interest rate for the six months ended June 30, 2026 was 5.1%. The issuance of these senior notes resulted in the Company incurring financing fees of $3.9 million that have been deferred and will be recognized over the term of the senior notes. Based on quoted prices, the fair value of the 4.9% Senior Unsecured Notes was $398.7 million at June 30, 2026. In conjunction with the issuance of the 4.9% Senior Unsecured Notes, the Company redeemed the $400 million in aggregate principal amount of 3.95% Senior Unsecured Notes that were due in February 2027. The redemption of these senior notes resulted in debt extinguishment costs of $0.7 million which were recorded in Other expense on the Condensed Consolidated Statements of Operations for the six months ended June 30, 2026. During the first quarter of 2025, the Company issued $300 million in aggregate principal amount of 5.875% Senior Unsecured Notes due in 2035. The interest rate on these senior notes may be increased by 0.25% each time a credit rating applicable to the notes is downgraded. The maximum rate is 7.875%. Interest on the notes is payable semiannually in arrears on February 26 and August 26 of each year, beginning on August 26, 2025. The effective interest rate for the six months ended June 30, 2026 was 6.0% inclusive of an approximately 0.10% benefit of treasury locks. The issuance of these senior notes resulted in the Company incurring financing fees of $3.9 million that have been deferred and will be recognized over the term of the senior notes. Based on quoted prices, the fair value of the 5.875% Senior Unsecured Notes was $310.2 million at June 30, 2026. In conjunction with the issuance of the 5.875% Senior Unsecured Notes, the Company redeemed the $300 million in aggregate principal amount of 4.7% Senior Unsecured Notes that were due in August 2025. The redemption of these senior notes resulted in debt extinguishment costs of $0.4 million which were recorded in Other expense on the Condensed Consolidated Statements of Operations for the six months ended June 30, 2025. Note 6 — Derivative Financial Instruments The Company entered into treasury lock agreements to protect against unfavorable movements in the benchmark treasury rate related to the issuance of our 5.875% Senior Unsecured Notes. These hedges were designated as cash flow hedges, thus any change in fair value was recorded as a component of other comprehensive income (loss). As part of the issuance of our 5.875% Senior Unsecured Notes, we net settled these derivatives for $3.6 million in cash and the deferred gains recorded in other comprehensive income (loss) will be released to interest expense over the life of the senior notes. The remaining balance of deferred gains as of June 30, 2026 was approximately $3.1 million. The effect of the settled treasury locks reduces the effective interest rate of the senior notes by approximately 0.10%. During the second quarter of 2026, in conjunction with the redemption of the $400 million in aggregate principal amount of 3.95% Senior Unsecured Notes, the Company recognized a gain of $0.8 million which was recorded in Other (income) expense on the Condensed Consolidated Statements of Operations. This amount related to the accelerated recognition of previously deferred gains for treasury lock agreements which the Company entered into to protect against unfavorable movements in the benchmark treasury rate related to the issuance of our 3.95% Senior Unsecured Notes in 2017. The deferred gains were being amortized over the life of the 3.95% Senior Unsecured Notes and recognized as a reduction to interest expense. Foreign Currency Forward Exchange Contracts 9 A number of our European subsidiaries are exposed to the impact of exchange rate volatility between the U.S. dollar and the subsidiaries’ functional currencies, being either the Euro or the British pound sterling. We have entered into contracts to exchange U.S. dollars for Euros and British pound sterling through December 2028. The aggregate notional amount of these contracts was $395.9 million and $403.4 million at June 30, 2026 and December 31, 2025, respectively. The purpose of these contracts is to hedge a portion of the forecasted transactions of our European subsidiaries under long-term sales contracts with certain customers. These contracts are expected to provide us with a more balanced matching of future cash receipts and expenditures by currency, thereby reducing our exposure to fluctuations in currency exchange rates. The effective portion of the hedges, losses of $1.5 million and $9.2 million were recorded in other comprehensive (loss) income for the quarter and six months ended June 30, 2026, respectively, and gains of $27.9 million and $39.8 million were recorded for the quarter and six months ended June 30, 2025, respectively. We recognized gains of $2.3 million and $6.1 million in gross margin during the quarters and six months ended June 30, 2026, respectively, and gains of $3.4 million and $1.8 million for the quarter and six months ended June 30, 2025, respectively. In addition, we enter into foreign exchange forward contracts which are not designated as hedges. These are used to provide an offset to transactional gains or losses arising from the remeasurement of non-functional monetary assets and liabilities such as accounts receivable. The change in the fair value of the derivatives is recorded in the Statement of Operations. There are no credit contingency features in these derivatives. During the quarter and six months ended June 30, 2026, we recognized net foreign exchange loss of $0.1 million and gains of $0.2 million in selling, general and administrative expenses, respectively, in the Condensed Consolidated Statements of Operations. During the quarter and six months ended June 30, 2025, we recognized net foreign exchange losses of $0.2 million and $0.3 million, respectively. The net foreign exchange impact recognized from these hedges offset the translation exposure of these transactions. The change in fair value of our foreign currency forward exchange contracts under hedge designations recorded net of tax within accumulated other comprehensive (loss) income for the quarters and six months ended June 30, 2026 and June 30, 2025 was as follows: Quarters Ended June 30, Six Months Ended June 30, (In millions) 2026 2025 2026 2025 Unrealized gains (losses) at beginning of period, net of tax $ 1.9 $ 2.1 $ 10.5 $ (7.9 ) (Gains) losses reclassified to net sales (2.1 ) (2.5 ) (5.1 ) (1.4 ) Increase (decrease) in fair value (0.6 ) 20.6 (6.2 ) 29.5 Unrealized (losses) gains at end of period, net of tax $ (0.8 ) $ 20.2 $ (0.8 ) $ 20.2 Unrealized gains of $0.9 million recorded in accumulated other comprehensive loss, less taxes of $0.2 million, as of June 30, 2026, are expected to be reclassified into earnings over the next twelve months as the hedged sales are recorded. Commodity Swap Agreements We use commodity swap agreements to hedge against price fluctuations of raw materials, including propylene (the principal component of acrylonitrile). As of June 30, 2026, we had commodity swap agreements with a notional value of $18.4 million. The swaps mature monthly through May 2028. The swaps are accounted for as a cash flow hedge of our forward raw material purchases. To ensure the swaps are highly effective, all of the critical terms of the swap matched the terms of the hedged items. The fair values of outstanding derivative financial instruments as of June 30, 2026 and December 31, 2025 were as follows: Prepaid and Other Current Assets Other Assets Current Liabilities Non-Current Liabilities (In millions) June 30, 2026 December 31, 2025 June 30, 2026 December 31, 2025 June 30, 2026 December 31, 2025 June 30, 2026 December 31, 2025 Derivative Products Foreign currency forward exchange contracts $ 3.8 $ 10.7 $ 0.5 $ 4.0 $ 2.9 $ 0.2 $ 2.3 $ 0.3 Undesignated hedges 0.1 — — — — — — — Commodity swaps 0.3 — — — 1.6 $ 3.6 0.5 $ 0.5 Total Derivative Products $ 4.2 $ 10.7 $ 0.5 $ 4.0 $ 4.5 $ 3.8 $ 2.8 $ 0.8 10 Note 7 — Fair Value Measurements The authoritative guidance for fair value measurements establishes a hierarchy for observable and unobservable inputs used to measure fair value, into three broad levels, which are described below: •Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs. •Level 2: Observable prices that are based on inputs not quoted on active markets but corroborated by market data. •Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs. In determining fair value, we utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as consider our own and counterparty credit risk in our assessment of fair value. We have no assets or liabilities that utilize Level 3 inputs. For derivative assets and liabilities that utilize Level 2 inputs, we prepare estimates of future cash flows of our derivatives, which are discounted to a net present value. The estimated cash flows and the discount factors used in the valuation model are based on observable inputs and incorporate non-performance risk (the credit standing of the counterparty when the derivative is in a net asset position, and the credit standing of Hexcel when the derivative is in a net liability position). For further information on the fair value of our derivative financial instruments see Note 6, Derivative Financial Instruments. In addition, the fair value of these derivative contracts, which are subject to a master netting arrangement under certain circumstances, is presented on a gross basis in the Condensed Consolidated Balance Sheets. Below is a summary of valuation techniques for all Level 2 financial assets and liabilities: •Foreign exchange derivative assets and liabilities — valued using quoted forward foreign exchange prices at the reporting date. •Commodity swap agreements — valued using quoted forward commodity prices at the reporting date. Counterparties to the above contracts are highly rated financial institutions, none of which experienced any significant downgrades in the quarter ended June 30, 2026 that would reduce the receivable amount owed, if any, to the Company. Note 8 — Revenue Our revenue is primarily derived from the sale of inventory under long-term contracts with our customers. We have determined that individual purchase orders (“PO”), the terms and conditions of which are taken with a master agreement, create the ASC 606 contracts, which are generally short-term in nature. For those sales that are not tied to a long-term agreement, we generate a PO that is subject to our standard terms and conditions. In instances where our customers acquire our goods related to government contracts, the contracts are typically subject to terms similar, or equal to, the Federal Acquisition Regulation Part 52.249-2. This regulation contains a termination for convenience clause (“T for C”), which requires that the customer pay for the cost of both the finished and unfinished goods at the time of cancellation plus a reasonable profit. We recognize revenue over time for those agreements that have T for C, and where the products being produced have no alternative use. As our production cycle is typically nine months or less, it is expected that goods related to the revenue recognized over time will be shipped and billed within the next twelve months. Less than half of our agreements contain provisions which would require revenue to be recognized over time. All other revenue is recognized at a point in time. We disaggregate our revenue based on market for analytical purposes. The following table details our revenue by market for the quarters and six months ended June 30, 2026 and 2025: Quarters Ended June 30, Six Months Ended June 30, (In millions) 2026 2025 2026 2025 Consolidated Net Sales $ 529.3 $ 489.9 $ 1,030.8 $ 946.4 Commercial Aerospace 346.6 293.1 679.3 573.2 Defense, Space & Other 182.7 196.8 351.5 373.2 11 Revenue recognized over time gives rise to contract assets, which represent revenue recognized but unbilled. Contract assets are included in our Condensed Consolidated Balance Sheets as a component of current assets. The activity related to contract assets for the six months ended June 30, 2026 was as follows: (In millions) Composite Material Engineered Products Total Balance at December 31, 2025 $ 11.4 $ 24.5 $ 35.9 Net revenue billed 1.2 3.3 4.5 Balance at March 31, 2026 12.6 27.8 40.4 Net revenue billed 2.0 (0.8 ) 1.2 Balance at June 30, 2026 $ 14.6 $ 27.0 $ 41.6 Accounts receivable, net, includes amounts billed to customers where the right to payment is unconditional. Note 9 — Segment Information The financial results for our operating segments are prepared using a management approach, which is consistent with the basis and manner in which we internally segregate financial information for the purpose of assisting in making internal operating decisions. We evaluate the performance of our operating segments based on operating income, and generally account for intersegment sales based on arm’s length prices. Corporate and certain other expenses are not allocated to the operating segments, except to the extent that the expense can be directly attributable to the business segment. We have two reportable segments: Composite Materials and Engineered Products. The Composite Materials segment is comprised of our carbon fiber, specialty reinforcements, resin systems, prepregs and other fiber-reinforced matrix materials, and honeycomb core product lines and pultruded profiles. The Engineered Products segment is comprised of lightweight high strength composite structures, radio frequency/electromagnetic interference (“RF/EMI”) and microwave absorbing materials, engineered core and specialty machined honeycomb products with added functionality. Financial information for our operating segments for the quarters and six months ended June 30, 2026 and 2025 were as follows: 12 Composite Engineered Corporate & (In millions) Materials Products Other (a) Total Quarter Ended June 30, 2026 Net sales to external customers $ 421.5 $ 107.8 $ — $ 529.3 Intersegment sales 27.2 1.5 (28.7 ) — Total sales 448.7 109.3 (28.7 ) 529.3 Cost of sales 331.8 87.8 (28.4 ) 391.2 Gross margin 116.9 21.5 (0.3 ) 138.1 Selling, general and administrative expenses 25.9 3.7 17.6 47.2 Research and development expenses 15.8 1.4 0.1 17.3 Other operating expense 1.0 — — 1.0 Operating income (loss) 74.2 16.4 (18.0 ) 72.6 Depreciation and amortization 27.0 3.1 - 30.1 Stock-based compensation 1.2 0.3 3.7 5.2 Accrual basis additions to capital expenditures 16.9 2.6 — 19.5 Quarter Ended June 30, 2025 Net sales to external customers $ 393.2 $ 96.7 $ — $ 489.9 Intersegment sales 19.4 0.4 (19.8 ) — Total sales 412.6 97.1 (19.8 ) 489.9 Cost of sales 315.7 81.5 (18.8 ) 378.4 Gross margin 96.9 15.6 (1.0 ) 111.5 Selling, general and administrative expenses 26.3 4.0 12.7 43.0 Research and development expenses 12.3 1.0 1.0 14.3 Other operating expense — 24.2 — 24.2 Operating income (loss) 58.3 (13.6 ) (14.7 ) 30.0 Depreciation and amortization 27.5 3.3 — 30.8 Stock-based compensation 0.9 0.2 1.6 2.7 Accrual basis additions to capital expenditures 13.1 1.6 — 14.7 Six Months Ended June 30, 2026 Net sales to external customers $ 820.3 $ 210.5 $ — $ 1,030.8 Intersegment sales 55.6 3.1 (58.7 ) — Total sales 875.9 213.6 (58.7 ) 1,030.8 Cost of sales 645.1 171.3 (58.4 ) 758.0 Gross margin 230.8 42.3 (0.3 ) 272.8 Selling, general and administrative expenses 48.2 7.8 40.6 96.6 Research and development expenses 32.0 2.9 0.2 35.1 Other operating expense 6.7 — 4.2 10.9 Operating income (loss) 143.9 31.6 (45.3 ) 130.2 Depreciation and amortization 54.2 6.3 — 60.5 Stock-based compensation 4.6 1.1 8.8 14.5 Accrual basis additions to capital expenditures 32.9 4.3 — 37.2 Six Months Ended June 30, 2025 Net sales to external customers $ 758.5 $ 187.9 $ — $ 946.4 Intersegment sales 39.5 0.7 (40.2 ) — Total sales $ 798.0 $ 188.6 $ (40.2 ) $ 946.4 Cost of sales 609.2 161.4 (38.1 ) 732.5 Gross margin 188.8 27.2 (2.1 ) 213.9 Selling, general and administrative expenses 51.8 8.3 26.2 86.3 Research and development expenses 24.1 2.1 1.9 28.1 Other operating expense — 25.3 — 25.3 Operating income (loss) 112.9 (8.5 ) (30.2 ) 74.2 13 Depreciation and amortization 54.1 6.5 — 60.6 Stock-based compensation 3.9 1.0 7.5 12.4 Accrual basis additions to capital expenditures 28.6 3.2 — 31.8 (a)We do not allocate corporate expenses to the operating segments. Goodwill and Intangible Assets Composite Engineered (In millions) Materials Products Total Balance at December 31, 2025 $ 89.9 $ 149.9 $ 239.8 Amortization expense (0.8 ) (2.0 ) (2.8 ) Currency translation adjustments (1.4 ) — (1.4 ) Balance at June 30, 2026 $ 87.7 $ 147.9 $ 235.6 At June 30, 2026, the balance of goodwill and intangible assets was $190.4 million and $45.2 million, respectively. Composite Engineered Corporate & (In millions) Materials Products Other Total Segment assets June 30, 2026 $ 2,078.0 $ 625.4 $ 27.2 $ 2,730.6 December 31, 2025 2,066.7 596.2 41.1 2,704.0 Note 10 — Accumulated Other Comprehensive Loss Comprehensive loss represents net loss and other gains and losses affecting stockholders’ equity that are not reflected in the Condensed Consolidated Statements of Operations. The components of accumulated other comprehensive loss as of June 30, 2026 and December 31, 2025 were as follows: (In millions) Unrecognized Net Defined Benefit and Postretirement Plan Costs Change in Fair Value of Derivatives Products (1) Foreign Currency Translation Total Balance at December 31, 2025 $ (1.1 ) $ 11.1 $ (22.9 ) $ (12.9 ) Other comprehensive loss before reclassifications (0.2 ) (5.8 ) (20.0 ) (26.0 ) Amounts reclassified from accumulated other comprehensive loss — (4.9 ) — (4.9 ) Other comprehensive loss (0.2 ) (10.7 ) (20.0 ) (30.9 ) Balance at June 30, 2026 $ (1.3 ) $ 0.4 $ (42.9 ) $ (43.8 ) (1)Includes forward foreign exchange contracts, interest rate derivatives and commodity swaps. The amount of net (gains) losses reclassified to earnings from the unrecognized net defined benefit and postretirement plan costs and derivative products components of accumulated other comprehensive loss for the quarters and six months ended June 30, 2026 and 2025 were as follows: 14 Quarter Ended June 30, 2026 Quarter Ended June 30, 2025 Six Months Ended June 30, 2026 Six Months Ended June 30, 2025 (In millions) Pre-tax loss (gain) Net of tax loss (gain) Pre-tax (gain) loss Net of tax (gain) loss Pre-tax loss (gain) Net of tax loss (gain) Pre-tax (gain) loss Net of tax (gain) loss Defined Benefit and Postretirement Plan Costs $ — $ — $ 0.9 $ 0.7 $ — $ — $ 0.9 $ 0.7 Derivative Products Foreign currency forward exchange contracts $ (2.3 ) $ (2.1 ) $ (3.4 ) $ (2.5 ) $ (6.1 ) $ (5.0 ) $ (1.8 ) $ (1.4 ) Commodity swaps (0.4 ) (0.3 ) (0.2 ) (0.2 ) 0.1 0.1 (0.4 ) (0.3 ) Interest rate swaps — — 6.3 4.9 — — 9.0 7.0 Total Derivative Products $ (2.7 ) $ (2.4 ) $ 2.7 $ 2.2 $ (6.0 ) $ (4.9 ) $ 6.8 $ 5.3 Note 11 — Commitments and Contingencies We are involved in litigation, investigations and claims arising out of the normal conduct of our business, including those relating to commercial transactions, environmental, employment and health and safety matters. While it is impossible to predict the ultimate resolution of litigation, investigations and claims asserted against us, we believe, based upon our examination of currently available information, our experience to date, and advice from legal counsel, that, after taking into account our existing insurance coverage and amounts already provided for, the currently pending legal proceedings against us will not have a material adverse impact on our consolidated results of operations, financial position or cash flows. Environmental Matters We have been named as a potentially responsible party (“PRP”) with respect to the below and other hazardous waste disposal sites that we do not own or possess, which are included on, or proposed to be included on, the Superfund National Priority List of the U.S. Environmental Protection Agency (“EPA”) or on equivalent lists of various state governments. Because the Federal Comprehensive Environmental Response, Compensation and Liability Act (“CERCLA” or “Superfund”) allows for joint and several liability in certain circumstances, we could be responsible for all remediation costs at such sites, even if we are one of many PRPs. We believe, based on the amount and nature of the hazardous waste at issue, and the number of other financially viable PRPs at each site, that our liability in connection with such environmental matters will not be material. Lower Passaic River Study Area Hexcel, together with approximately 48 other PRPs that comprise the Lower Passaic Cooperating Parties Group (the “CPG”), are subject to a May 2007 Administrative Order on Consent (“AOC”) with the EPA requiring the CPG to perform a Remedial Investigation/Feasibility Study of environmental conditions of a 17-mile stretch of the Passaic River in New Jersey (the “Lower Passaic River”). We were included in the CPG based on our operations at our former manufacturing site in Lodi, New Jersey. In March 2016, the EPA issued a Record of Decision (“ROD”) setting forth the EPA’s selected remedy for the lower eight miles of the Lower Passaic River at an expected cost ranging from $0.97 billion to $2.07 billion. In August 2017, the EPA appointed an independent third-party allocation expert to make recommendations on the relative liability of approximately 120 identified non-government PRPs for the lower eight miles of the Lower Passaic River. In December 2020, the allocator issued its non-binding report on PRP liability (including Hexcel’s) to the EPA. In October 2021, the EPA released a ROD selecting an interim remedy for the upper nine miles of the Lower Passaic River at an expected additional cost ranging from $308.7 million to $661.5 million. In October 2016, pursuant to a settlement agreement with the EPA, Occidental Chemical Corporation (“OCC”), one of the PRPs, commenced performance of the remedial design required by the ROD for the lower eight miles of the Lower Passaic River, reserving its right of cost contribution from all other PRPs. In June 2018, OCC filed suit against approximately 120 parties, including Hexcel, in the U.S. District Court of the District of New Jersey seeking cost recovery and contribution under CERCLA related to the Lower Passaic River. In July 2019, the court granted in part and denied in part the defendants’ motion to dismiss. In August 2020, the court granted defendants’ motion for summary judgment for certain claims. Discovery for the remaining claims has been stayed indefinitely based on agreement of the parties. On February 24, 2021, Hexcel and certain other defendants filed a third-party complaint against the Passaic Valley Sewerage Commission and certain New Jersey municipalities seeking recovery of Passaic-related cleanup costs incurred by defendants, as well as contribution for any cleanup costs incurred by OCC for which the court deems the defendants 15 liable. In March 2023, the EPA issued a Unilateral Administrative Order (“UAO”) to OCC ordering OCC to commence remedial design work for the interim remedy for the cleanup of the upper nine miles of the Lower Passaic River. On March 24, 2023, OCC filed suit against Hexcel and approximately 38 other parties claiming cost recovery under CERCLA for future costs related to its compliance with the UAO. On January 5, 2024, the U.S. District Court stayed the foregoing claim initiated by OCC until the completion of the Passaic-related Consent Decree process. On December 16, 2022, the EPA lodged a Consent Decree with the U.S. District Court for the District of New Jersey requesting court approval of a $150 million settlement of the EPA’s CERCLA claims against Hexcel and 83 other PRPs for costs related to alleged contamination of the upper and lower portions of the Lower Passaic River. The 84 PRPs have collectively placed $150 million in escrow, pending District Court approval of the Consent Decree. In December 2024, the District Court granted the issuance of the Consent Decree, however, this decision has been appealed. Briefing on the appeal was completed in January 2026. Summary of Environmental Reserves Our estimate of liability as a PRP and our remaining costs associated with our responsibility to remediate the Lower Passaic River and other sites are accrued in the Consolidated Balance Sheets. As of both June 30, 2026 and December 31, 2025, our aggregate environmental related accruals were $0.1 million. These amounts were included in non-current liabilities. These accruals can change significantly from period to period due to such factors as additional information on the nature or extent of contamination, the methods of remediation required, changes in the apportionment of costs among responsible parties and other actions by governmental agencies or private parties, or the impact, if any, of being named in a new matter. Product Warranty We provide standard assurance-type warranties for our products, which cannot be purchased separately and do not meet the criteria to be considered a performance obligation. Warranty expense for the six months ended June 30, 2026, and accrued warranty cost, included in “accrued liabilities” in the Condensed Consolidated Balance Sheets at June 30, 2026 and December 31, 2025, were as follows: Product (In millions) Warranties Balance as of December 31, 2025 $ 3.0 Warranty expense 1.1 Deductions and other (1.1 ) Balance as of March 31, 2026 $ 3.0 Warranty expense 0.8 Deductions and other (0.4 ) Balance as of June 30, 2026 $ 3.4 Note 12 — Restructuring We recognized restructuring charges of $1.0 million and $6.5 million, respectively, for both the quarter and six months ended June 30, 2026, related to the shutdown of industrial-oriented manufacturing at the Leicester, UK facility. These amounts were included in Other operating expense. Anticipated future cash payments as of June 30, 2026 were $5.2 million. Activity for the Quarter Ended June 30, 2026 March 31, Restructuring Cash June 30, (In Millions) 2026 Charge FX Impact Paid Non-Cash 2026 Employee termination $ 2.8 $ 0.1 $ — $ (2.5 ) $ — $ 0.4 Impairment and other 4.1 0.9 0.1 — (0.2 ) 4.8 Total $ 6.9 $ 1.0 $ 0.1 $ (2.5 ) $ (0.2 ) $ 5.2 Activity for the Six Months Ended June 30, 2026 December 31, Restructuring Cash June 30, (In Millions) 2025 Charge FX Impact Paid Non-Cash 2026 Employee termination $ 2.5 $ 2.4 $ (0.1 ) $ (4.4 ) $ — $ 0.4 Impairment and other 3.0 4.1 — — (2.3 ) 4.8 Total $ 5.5 $ 6.5 $ (0.1 ) $ (4.4 ) $ (2.3 ) $ 5.2 16 Note 13 — Capital Stock On February 19, 2024, the Board approved a $300 million share repurchase plan (the “2024 Share Repurchase Plan”). As of December 31, 2025, the 2024 Share Repurchase Plan was fully utilized. The repurchases of the Company’s common stock under the 2024 Share Repurchase Plan were made in open market transactions, block transactions, privately negotiated purchase transactions or other purchase techniques at the discretion of management based upon consideration of market, business, legal, accounting, and other factors. On October 22, 2025, the Board approved an additional $600 million share repurchase plan (the "2025 Share Repurchase Plan"), and, as part of the 2025 Share Repurchase Plan, the Company entered into accelerated share repurchase agreements (the "ASR") to purchase an aggregate of $350 million of the Company's common stock. On October 24, 2025, the Company paid Bank of America, N.A. (“Bank of America”) and Goldman Sachs & Co. LLC (together with Bank of America, the “Counterparties”) an aggregate amount of $350 million and received an initial delivery of approximately 3.95 million shares of the Company's common stock, representing 80% of the shares expected to be repurchased under the ASR agreement, at a price of $70.95 per share, which was the closing price of our common stock on October 24, 2025. The final settlement under the ASR program with Bank of America occurred on February 27, 2026 and with Goldman Sachs & Co. LLC on March 3, 2026, at which time we received additional shares of approximately 0.57 million. In total, we received 4.52 million shares under the ASR agreement. The total shares received were calculated based on a price per share of $77.38 per share which was based on the average of the daily volume-weighted average prices of the Company’s common stock during the term of the ASR Agreements, less a discount and subject to adjustments pursuant to the terms and conditions of the ASR Agreements. During the second quarter of 2026, there were no repurchases of Company shares. As of June 30, 2026, the Company had approximately $380.6 million available for additional repurchases under the 2025 Share Repurchase Plan. 17